Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6119881 | Journal of Clinical Virology | 2016 | 6 Pages |
Abstract
HEV genotype 3 viremia mainly presents in patients with underlying chronic liver diseases or an impaired immune system. Patients with pre-existent liver diseases are at high risk for complications and even death. The off-label use of ribavirin can cure HEV infection.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Charlotte M. Nijskens, Suzan D. Pas, Jan Cornelissen, Kadir Caliskan, Rogier A.S. Hoek, Dennis A. Hesselink, Annemiek A. van der Eijk, Robert A. de Man,